Cutamesine attenuates hippocampal damage via sigma-1 receptor activation following oxygen-glucose deprivation in vitro. (PubMed, Brain Res)
These findings evidence the notion that the sigma-1 receptor may be a promising therapeutic target for ischemic injury. Abbreviations: aCSF, artificial cerebrospinal fluid; AD, anoxic depolarization; Cornu Ammonis 1, CA1; ER, endoplasmic reticulum; fEPSP, field excitatory postsynaptic potentials; GRP78, 78-kDa glucose-regulated protein; GRP94, glucose-regulated protein 94; IL-1β, interleukin-1 beta; MAMs, mitochondria-associated membranes; MMP-9, matrix metalloproteinase-9; OGD, oxygen and glucose deprivation; PI, propidium iodide; p-NF-κB, phosphorilated nuclear factor -kappa-B p65 subunit (p-p65); ROS, reactive oxygen species; Sig-1 receptor, sigma-1 receptor; TNF-α, tumor necrosis factor-alpha; UPR, unfolded protein response.